StonvexLoading…
StonvexStonvexStonvexCore line items from MMS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $5.43B | $5.31B | $4.90B | $4.63B |
Operating Income | $528.29M | $488.50M | $294.79M | $325.90M |
Net Income | $319.03M | $306.91M | $161.79M | $203.83M |
EPS (Diluted) | $5.51 | $4.99 | $2.63 | $3.29 |
Total Assets | $4.07B | $4.13B | $3.99B | $3.99B |
Total Liabilities | $2.40B | $2.29B | $2.32B | $2.44B |
Cash & Equivalents | $222.35M | $183.12M | $65.41M | $40.66M |
Free Cash Flow OCF − CapEx | $366.16M | $401.07M | $223.65M | $233.69M |
Shares Outstanding | 54.80M | 60.35M | 61.00M | 60.77M |